Benjamin Wahle, MD

Benjamin Wahle, MD

MD: Indiana University School of Medicine

Hometown: Indianapolis, IN

Personal Statement: I chose a career in Otolaryngology because I wanted to work with patients with issues related to the special functions of the head and neck, especially hearing and communications disorders. I chose Washington University for residency training because of the outstanding faculty and residents who are committed to excellence in both their clinical and academic pursuits. My research interests include neurofibromatosis 2 and vestibular schwannomas. In my free time, I enjoy playing guitar and banjo, spending time outside, skiing, and trying new restaurants.


Undergraduate: Indiana University, Bloomington; BS in Biology, 2012

Medical School: Indiana University School of Medicine, 2017

Honors and Awards

  • Alpha Omega Alpha Honor Medical Society, 2016
  • Gold Humanism Honor Society, 2015
  • Indiana Academy of OHNS Edward C. Weisberger, M.D. Award, 2017
  • Melvin and Bren Simon Cancer Center’s William J. Wright Scholarship, 2016
  • Janice M. Pascuzzi Scholarship for Excellence in Compassionate Care, 2015
  • Phi Beta Kappa Honor Society – Indiana University, Bloomington, 2012


Wahle B, Meyer K, Faller M, Kochhar K, Sevilla J. Assessment of Hypertension Management and Outcomes at an Indianapolis Student-Run Free Clinic. J Health Care Poor Underserved. 2017;28(2):694-706.

Wahle, Benjamin M.; Hawley, Eric T.; He, Yongzheng; Smith, Abbi E.; Yuan, Jin; Masters, Andi R.; Jones, David R.; Gehlhausen, Jeffrey R.; Park, Su-Jung; Conway, Simon J.; Wade Clapp, D.; Yates, Charles W. Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2. Oncotarget. 2017 Oct 24.